MEMBER'S LOGINX
| Login Failure | ||||||||
|
||||||||
| Sign Up | Forgot Password? | ||||||||
- Home
- Todays Market
- Indian Stock Market Updates June 19, 2019
STRIDES PHARMA SCIENCE Plunges by 5%; BSE HEALTHCARE Index Down 1.4%
Wed, 19 Jun 02:38 PM
STRIDES PHARMA SCIENCE share price has plunged 5% and is presently trading at Rs 416.
Meanwhile, the BSE HEALTHCARE Index is at 12,729 (down 1.4%).
Among the top losers in the BSE HEALTHCARE Index today are STRIDES PHARMA SCIENCE (down 5.1%) and PIRAMAL ENTERPRISES (down 5.2%).
BIOCON (up 2.3%) and CAPLIN POINT (up 2.3%) are among the top gainers today.
Over the last one year, STRIDES PHARMA SCIENCE has moved up from Rs 405 to Rs 416, registering a gain of Rs 11 (up 2.8%)..
The BSE HEALTHCARE has moved down from 14,312 to 12,729, loss of 1,583 points (down 11.1%) during the last 12 months.
The top gainers among the BSE HEALTHCARE Index stocks during this same period were MERCK (up 62.3%), DIVIS LABORATORIES (up 40.4%) and IPCA LABS (up 34.4%).
Revealed: Top 3 Stocks for 2020 and Beyond
What About the Benchmark Indices?
The BSE Sensex is at 39,436 (down 0.1%). The top gainers among the BSE Sensex stocks today are TATA STEEL (up 2.8%). The most traded stocks in the BSE Sensex are TATA STEEL and ITC.
In the meantime, NSE Nifty is at 11,802 (down 0.3%). TATA STEEL (up 2.8%) and ZEE ENTERTAINMENT (up 2.3%) are among the top gainers in NSE Nifty.
Over the last 12 months, the BSE Sensex has moved up from 35,548 to 39,436, registering a gain of 3,888 points (up 9.8%).
STRIDES PHARMA SCIENCE Financial Update...
STRIDES PHARMA SCIENCE net profit stood at Rs 650 million for the quarter ended March 2019, compared to a profit of Rs 316 million a year ago. Net Sales rose 5.7% to Rs 8.4 billion during the period as against Rs 7.9 billion in January-March 2018.
For the year ended March 2018, STRIDES PHARMA SCIENCE reported 58.6% decrease in net profit to Rs 1.3 billion compared to net profit of Rs 3.2 billion during FY17.
Revenue of the company grew 3.0% to Rs 28 billion during FY18.
The current Price to earnings ratio of STRIDES PHARMA SCIENCE, based on rolling 12 month earnings, stands at 33.4x.
Indian Share Market Update: Top Gainers and Losers
What else is happening in the markets today? Dig in...
- TRACK NOW:
- Most Active Stocks Rs 0 to 10
- Most Active Stocks Rs 10 to 20
- BSE A Group Gainers Today
- NSE Above Rs 20 Gainers Today
- BSE Above Rs 20 Gainers Today
- BSE Sensex Gainers Today
- BSE Small Cap Gainers Today
- BSE 500 Gainers Today
- BSE A Group Losers Today
- Most Active Stocks Rs 1 to 2
- NSE Above Rs 20 Losers Today
- Buzzing Stocks Today
Stock Market Updates
NESCO Share Price Up by 12%; BSE REALTY Index Down 0.0% (Today's Market)
Aug 11, 2020 10:41 AMNESCO share price is trading up by 12% and its current market price is Rs 509. The BSE REALTY is down by 0.0%. The top gainers in the BSE REALTY Index are NESCO (up 12.3%) and INDIABULLS REAL EST (up 8.5%). The top losers are DLF (down 0.3%) and OBEROI REALTY (down 1.8%).
J.B.CHEMICALS at All Time High; BSE HEALTHCARE Index Down 0.4% (Today's Market)
Aug 11, 2020 10:41 AMJ.B.CHEMICALS share price has hit an all time high at Rs 777 (up 5.2%). The BSE HEALTHCARE Index is down by 0.4%. Among the top gainers in the BSE HEALTHCARE Index today are J.B.CHEMICALS (up 5.2%) and ABBOTT INDIA (up 0.4%). The top losers include LUPIN (down 0.2%) and SUN PHARMA (down 0.2%).
LA OPALA RG Share Price Up by 11%; BSE 500 Index Up 0.7% (Today's Market)
Aug 11, 2020 10:33 AMLA OPALA RG share price is trading up by 11% and its current market price is Rs 214. The BSE 500 is up by 0.7%. The top gainers in the BSE 500 Index are LA OPALA RG (up 10.6%) and GARWARE TECHNICAL (up 14.5%). The top losers are PI INDUSTRIES and BRITANNIA .
HINDUSTAN COPPER Share Price Up by 7%; BSE METAL Index Up 2.7% (Today's Market)
Aug 11, 2020 10:31 AMHINDUSTAN COPPER share price is trading up by 7% and its current market price is Rs 40. The BSE METAL is up by 2.7%. The top gainers in the BSE METAL Index are HINDUSTAN COPPER (up 7.2%) and HINDUSTAN ZINC (up 5.2%). The top losers [TOPLOSERS].
MPHASIS at 52 Week High; BSE 500 Index Up 1.0% (Today's Market)
Aug 11, 2020 10:29 AMMPHASIS share price has hit a 52-week high. It is presently trading at Rs 1,232. BSE 500 Index is up by 0.7% at 14,843. Within the BSE 500, MPHASIS (up 3.1%) and GARWARE TECHNICAL (up 14.4%) are among the top gainers, while top losers are VA TECH WABAG and HIMACHAL FUTURISTIC.
Sensex Opens Over 300 Points Up; ICICI Bank and Axis Bank among Top Gainers (Today's Market)
Aug 11, 2020 09:30 amAsian stock markets are higher today as Chinese and Hong Kong shares show gains. The Shanghai Composite is up 0.5% while the Hang Seng is up 2.4%.
View More Indian Share Market NewsMost Popular
Before You Buy Your First Electric Vehicle Consider Buying this Stock(Profit Hunter)
Jul 29, 2020As competition intensifies in the electric vehicle space, only few will create huge wealth over the years.
Large Opportunities Are Coming Our Way
Aug 5, 2020Kenneth Andrade tells us why stocks will bounce back strongly and what he's bullish on.
Is It Time to Book Profits in Gold and Silver?(Fast Profits Daily)
Aug 10, 2020Gold and silver have delivered phenomenal returns this year. Is it time to take some money of the table?
This 20 Year Cycle Suggests Gold is Set for an August Rally(Profit Hunter)
Jul 31, 2020The real reason why gold prices will go up more.
MoreOUR TOP 5 IDEAS
- Free Report: Multibagger Stock Ideas 2020
- Are You Making One of These 15 Costly Mistakes While Investing. Learn more!
- Covid-19 Proof Multibagger Stocks - Download this FREE Report Now
- Free Report: The Secret to Increasing Your Trading Profits Daily!
- No Guessing, No Hunches, and No Missed Trends Ever! Join Us on YouTube Now.
S&P BSE SENSEX
Aug 11, 2020 11:27 AM
MARKET STATS
ABOUT EQUITYMASTER
Since 1996, Equitymaster has been the source for honest and credible opinions on investing in India. With solid research and in-depth analysis Equitymaster is dedicated towards making its readers- smarter, more confident and richer every day. Here's why hundreds of thousands of readers spread across more than 70 countries Trust Equitymaster.
FREE NEWSLETTERS
PREMIUM PRODUCTS
QUICK LINKS
APPS
Copyright © Equitymaster Agora Research Private Limited.
Whitelist | Refer | Terms | Privacy | Contact | About | Sitemap
Equitymaster Agora Research Private Limited (Research Analyst) 103, Regent Chambers, Above Status Restaurant, Nariman Point, Mumbai - 400 021. India.
Telephone: +91-22-61434055. Fax: +91-22-22028550. Email: info@equitymaster.com. Website: www.equitymaster.com. CIN:U74999MH2007PTC175407
All rights reserved. Any act of copying, reproducing or distributing this newsletter whether wholly or in part, for any purpose without the permission of Equitymaster is strictly prohibited and shall be deemed to be copyright infringement.
LEGAL DISCLAIMER: Equitymaster Agora Research Private Limited (Research Analyst) bearing Registration No. INH000000537 (hereinafter referred as 'Equitymaster') is an independent equity research Company. Equitymaster is not an Investment Adviser. Information herein should be regarded as a resource only and should be used at one's own risk. This is not an offer to sell or solicitation to buy any securities and Equitymaster will not be liable for any losses incurred or investment(s) made or decisions taken/or not taken based on the information provided herein. Information contained herein does not constitute investment advice or a personal recommendation or take into account the particular investment objectives, financial situations, or needs of individual subscribers. Before acting on any recommendation, subscribers should consider whether it is suitable for their particular circumstances and, if necessary, seek an independent professional advice. This is not directed for access or use by anyone in a country, especially, USA, Canada or the European Union countries, where such use or access is unlawful or which may subject Equitymaster or its affiliates to any registration or licensing requirement. All content and information is provided on an 'As Is' basis by Equitymaster. Information herein is believed to be reliable but Equitymaster does not warrant its completeness or accuracy and expressly disclaims all warranties and conditions of any kind, whether express or implied. Equitymaster may hold shares in the company/ies discussed herein. As a condition to accessing Equitymaster content and website, you agree to our Terms and Conditions of Use, available here. The performance data quoted represents past performance and does not guarantee future results.
SEBI (Research Analysts) Regulations 2014, Registration No. INH000000537.
Equitymaster requests your view! Post a comment on "STRIDES PHARMA SCIENCE Plunges by 5%; BSE HEALTHCARE Index Down 1.4%". Click here!
Comments are moderated by Equitymaster, in accordance with the Terms of Use, and may not appear
on this article until they have been reviewed and deemed appropriate for posting.
In the meantime, you may want to share this article with your friends!